TD Asset Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Buy |
192,506
+10,108
| +6% | +$162K | ﹤0.01% | 844 |
|
|
2025
Q1 | $3.12M | Buy |
182,398
+30,152
| +20% | +$515K | ﹤0.01% | 862 |
|
|
2024
Q4 | $3.77M | Buy |
152,246
+67,246
| +79% | +$1.67M | ﹤0.01% | 845 |
|
|
2024
Q3 | $2.38M | Buy |
85,000
+48,200
| +131% | +$1.35M | ﹤0.01% | 978 |
|
|
2024
Q2 | $972K | Sell |
36,800
-32,242
| -47% | -$851K | ﹤0.01% | 1167 |
|
|
2024
Q1 | $2.23M | Buy |
69,042
+2,734
| +4% | +$88.3K | ﹤0.01% | 981 |
|
|
2023
Q4 | $2.79M | Buy |
66,308
+35,108
| +113% | +$1.48M | ﹤0.01% | 903 |
|
|
2023
Q3 | $1.2M | Buy |
+31,200
| New | +$1.2M | ﹤0.01% | 1103 |
|
|
2023
Q2 | – | Sell |
-29,900
| Closed | -$464K | – | 1441 |
|
|
2023
Q1 | $464K | Buy |
29,900
+11,100
| +59% | +$172K | ﹤0.01% | 1276 |
|
|
2022
Q4 | $334K | Buy |
+18,800
| New | +$334K | ﹤0.01% | 1342 |
|
|
2021
Q1 | – | Sell |
-16,300
| Closed | -$753K | – | 1516 |
|
|
2020
Q4 | $753K | Buy |
16,300
+5,117
| +46% | +$236K | ﹤0.01% | 1247 |
|
|
2020
Q3 | $394K | Buy |
+11,183
| New | +$394K | ﹤0.01% | 1291 |
|